DVA – davita inc. (US:NASDAQ)

News

DaVita (DVA) was downgraded by Zacks Research from "strong-buy" to "hold".
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306
Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306
Yahoo Finance [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com